Rosemary Crane

Ms. Rosemary A. Crane is an Independent Director at Teva Pharmaceutical Industries Ltd., a Director-Discovery & Innovation at HMH Hospitals Corp, Inc. and a Member-Foundation Board at The State University of New York.
She is on the Board of Directors at Teva Pharmaceutical Industries Ltd. and Hackensack Meridian Health Center For Discovery & Innovation.
Ms. Crane was previously employed as an Independent Director by Certara, Inc., an Independent Director by Tarsus Pharmaceuticals, Inc., an Independent Director by Catalent, Inc., an Independent Director by Edge Therapeutics, Inc., an Independent Director by Unilife Corp., a Vice Chairman by Zealand Pharma A/S, a President, Chief Executive Officer & Director by MELA Sciences, Inc., a Partner by Apple Tree Venture Management Llc//vc, a President, Chief Executive Officer & Director by Epocrates LLC, a Group Chairman-OTC & Nutritional Group by Johnson & Johnson, a President-US Primary Care Division by Bristol Myers Squibb Co., and a President & Chief Executive Officer by Epocrates, Inc. (Research).
She also served on the board at Catalent Pharma Solutions, Inc., Cipher Pharmaceuticals, Inc., Targanta Therapeutics Corp.
and Unilife Medical Solutions, Inc. She received her undergraduate degree from State University of New York College at Oswego and an MBA from Kent State University (Ohio).